Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2021

01-04-2021 | Metastasis | Case Report

Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia

Authors: Yumeo Tateyama, Atsushi Naganuma, Yuhei Suzuki, Tomoyuki Masuda, Sanae Uehara, Takashi Hoshino, Hidetoshi Yasuoka, Tomohiro Kudo, Yusuke Ogawa, Tetsushi Ogawa, Kohei Tateno, Norihiro Ishii, Kenichiro Araki, Norifumi Harimoto, Ken Shirabe, Satoru Kakizaki

Published in: Clinical Journal of Gastroenterology | Issue 2/2021

Login to get access

Abstract

It is very difficult to treat patients with liver metastasis presenting with jaundice or cachexia. We herein report a successfully treated case of huge liver metastasis of gastrointestinal stromal tumor (GIST) that initially showed jaundice and cachexia. The patient was a woman in her early 40 s. She had a history of duodenal GIST 4 years before this admission. She was admitted to our hospital for abdominal fullness and anorexia. Abdominal computed tomography revealed huge liver metastasis of GIST. She showed jaundice and cancer cachexia with a modified Glasgow Prognostic Score of 2. After applying nutritional support, 400 mg of imatinib was administered. Although leg edema transiently worsened, the withdrawal of imatinib and administration of diuretics improved it. Imatinib was re-administered, and nutritional support was continued. The total bilirubin level decreased, and the serum albumin level increased. The tumor gradually decreased in size. Finally, she received surgical resection after 16 months of treatment with imatinib. Although adjuvant imatinib administration was continued after surgery, and no recurrence was observed as of 18 months after surgery.
Literature
1.
go back to reference Beham A, Schaefer IM, Cameron S, et al. Duodenal GIST: a single center experience. Int J Colorectal Dis. 2013;28:581–90.CrossRefPubMed Beham A, Schaefer IM, Cameron S, et al. Duodenal GIST: a single center experience. Int J Colorectal Dis. 2013;28:581–90.CrossRefPubMed
2.
go back to reference Taskovska M, Omejc M, Grosek J. Small gastrointestinal stromal tumour of the duodenum causing a life-threatening bleeding—a case report and review of the literature. Int J Surg Case Rep. 2019;57:160–2.CrossRefPubMedPubMedCentral Taskovska M, Omejc M, Grosek J. Small gastrointestinal stromal tumour of the duodenum causing a life-threatening bleeding—a case report and review of the literature. Int J Surg Case Rep. 2019;57:160–2.CrossRefPubMedPubMedCentral
3.
go back to reference Shen C, Chen H, Yin Y, et al. Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome. BMC Surg. 2015;15:98.CrossRefPubMedPubMedCentral Shen C, Chen H, Yin Y, et al. Duodenal gastrointestinal stromal tumors: clinicopathological characteristics, surgery, and long-term outcome. BMC Surg. 2015;15:98.CrossRefPubMedPubMedCentral
4.
go back to reference Santos AJ, Tojal A, Duarte L, et al. Asymptomatic large duodenal GIST—an incidental finding in abdominopelvic ultrasonography: a case report. Int J Surg Case Rep. 2020;76:301–4.CrossRefPubMedPubMedCentral Santos AJ, Tojal A, Duarte L, et al. Asymptomatic large duodenal GIST—an incidental finding in abdominopelvic ultrasonography: a case report. Int J Surg Case Rep. 2020;76:301–4.CrossRefPubMedPubMedCentral
5.
go back to reference Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8:S1-41.CrossRefPubMedPubMedCentral Demetri GD, von Mehren M, Antonescu CR, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8:S1-41.CrossRefPubMedPubMedCentral
6.
go back to reference Casali PG, Abecassis N, Aro HT, et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv68-78.CrossRefPubMed Casali PG, Abecassis N, Aro HT, et al. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29:iv68-78.CrossRefPubMed
7.
go back to reference Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003;21:4342–9.CrossRefPubMed Heinrich MC, Corless CL, Demetri GD, et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 2003;21:4342–9.CrossRefPubMed
8.
go back to reference Ramanathan RK, Egorin MJ, Takimoto CH, et al. Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group. J Clin Oncol. 2008;26:563–9.CrossRefPubMed Ramanathan RK, Egorin MJ, Takimoto CH, et al. Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of liver dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group. J Clin Oncol. 2008;26:563–9.CrossRefPubMed
9.
go back to reference Bauer S, Hagen V, Pielken HJ, et al. Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function. Anticancer Drugs. 2002;13:847–9.CrossRefPubMed Bauer S, Hagen V, Pielken HJ, et al. Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function. Anticancer Drugs. 2002;13:847–9.CrossRefPubMed
10.
go back to reference Hashimoto T, Amano T, Tomita N, et al. Two cases of gastric and intestinal gastrointestinal stromal tumors with multiple liver metastasis which complicated with liver dysfunction and successfully treated by ST1571. Operation. 2004;58:1489–92 (Article in Japanese). Hashimoto T, Amano T, Tomita N, et al. Two cases of gastric and intestinal gastrointestinal stromal tumors with multiple liver metastasis which complicated with liver dysfunction and successfully treated by ST1571. Operation. 2004;58:1489–92 (Article in Japanese).
11.
go back to reference Inoue Y, Iwata T, Okugawa Y, et al. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology. 2013;84:100–7.CrossRefPubMed Inoue Y, Iwata T, Okugawa Y, et al. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology. 2013;84:100–7.CrossRefPubMed
12.
go back to reference Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5 (Article in Japanese).PubMed Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi. 1984;85:1001–5 (Article in Japanese).PubMed
13.
go back to reference Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4.CrossRefPubMed Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4.CrossRefPubMed
14.
go back to reference Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11:8–13.CrossRefPubMed Detsky AS, McLaughlin JR, Baker JP, et al. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11:8–13.CrossRefPubMed
15.
go back to reference Iwasa M, Hara N, Iwata K, et al. Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease. Hepatol Res. 2010;40:1188–94.CrossRefPubMed Iwasa M, Hara N, Iwata K, et al. Restriction of calorie and iron intake results in reduction of visceral fat and serum alanine aminotransferase and ferritin levels in patients with chronic liver disease. Hepatol Res. 2010;40:1188–94.CrossRefPubMed
16.
go back to reference Popivanov G, Tabakov M, Mantese G, et al. Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review. Transl Gastroenterol Hepatol. 2018;3:71.CrossRefPubMedPubMedCentral Popivanov G, Tabakov M, Mantese G, et al. Surgical treatment of gastrointestinal stromal tumors of the duodenum: a literature review. Transl Gastroenterol Hepatol. 2018;3:71.CrossRefPubMedPubMedCentral
17.
go back to reference Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.CrossRefPubMed Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–78.CrossRefPubMed
18.
go back to reference Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36:1187–96.CrossRefPubMed Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36:1187–96.CrossRefPubMed
19.
go back to reference Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol. 2014;20:10537–44.CrossRefPubMedPubMedCentral Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer. World J Gastroenterol. 2014;20:10537–44.CrossRefPubMedPubMedCentral
20.
go back to reference Mohri Y, Inoue Y, Tanaka K, et al. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37:2688–92.CrossRefPubMed Mohri Y, Inoue Y, Tanaka K, et al. Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg. 2013;37:2688–92.CrossRefPubMed
21.
go back to reference Hirashima M, Higuchi S, Sakamoto K, et al. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;124:329–34.CrossRefPubMed Hirashima M, Higuchi S, Sakamoto K, et al. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;124:329–34.CrossRefPubMed
Metadata
Title
Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia
Authors
Yumeo Tateyama
Atsushi Naganuma
Yuhei Suzuki
Tomoyuki Masuda
Sanae Uehara
Takashi Hoshino
Hidetoshi Yasuoka
Tomohiro Kudo
Yusuke Ogawa
Tetsushi Ogawa
Kohei Tateno
Norihiro Ishii
Kenichiro Araki
Norifumi Harimoto
Ken Shirabe
Satoru Kakizaki
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
Clinical Journal of Gastroenterology / Issue 2/2021
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-021-01340-7

Other articles of this Issue 2/2021

Clinical Journal of Gastroenterology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.